Surmodics, Inc.
SRDX · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Revenue | $126,078 | $132,584 | $99,951 | $105,136 |
| % Growth | -4.9% | 32.6% | -4.9% | – |
| Cost of Goods Sold | $33,026 | $71,560 | $70,951 | $63,911 |
| Gross Profit | $93,052 | $61,024 | $29,000 | $41,225 |
| % Margin | 73.8% | 46% | 29% | 39.2% |
| R&D Expenses | $10,000 | $9,572 | $9,082 | $46,734 |
| G&A Expenses | $0 | $0 | $46,935 | $30,677 |
| SG&A Expenses | $56,836 | $51,884 | $46,947 | $30,680 |
| Sales & Mktg Exp. | $0 | $0 | $12 | $3 |
| Other Operating Expenses | $31,861 | $41,013 | -$4,932 | $3,342 |
| Operating Expenses | $98,697 | $102,469 | $51,097 | $80,756 |
| Operating Income | -$5,645 | $5,150 | -$22,097 | $6,703 |
| % Margin | -4.5% | 3.9% | -22.1% | 6.4% |
| Other Income/Exp. Net | -$1,861 | -$2,663 | -$396 | -$357 |
| Pre-Tax Income | -$7,506 | $2,487 | -$22,493 | $6,346 |
| Tax Expense | $4,036 | $4,023 | $4,781 | $2,109 |
| Net Income | -$11,542 | -$1,536 | -$27,274 | $4,237 |
| % Margin | -9.2% | -1.2% | -27.3% | 4% |
| EPS | -0.82 | -0.11 | -1.96 | 0.31 |
| % Growth | -645.5% | 94.4% | -732.3% | – |
| EPS Diluted | -0.82 | -0.11 | -1.96 | 0.3 |
| Weighted Avg Shares Out | 14,153 | 14,031 | 13,916 | 13,765 |
| Weighted Avg Shares Out Dil | 14,153 | 14,031 | 13,916 | 13,989 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3,540 | $3,489 | $598 | $310 |
| Depreciation & Amortization | $8,694 | $9,174 | $9,671 | $8,017 |
| EBITDA | $4,728 | $15,150 | -$12,224 | $14,673 |
| % Margin | 3.8% | 11.4% | -12.2% | 14% |